ResearcherNiigata UniversityActive in the last 2 years
Shuji Terai
Matched on ORCID iD 0000-0002-5439-635X; OpenAlex author ID A5021394925. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 4
2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper
Papers 4
- Mortality and cancer risk in patients with chronic pancreatitis in japan: insights into the importance of surveillance for pancreatic cancer. Co-author DOI 10.1007/s00535-025-02321-0↗
- Similarity of oncogenic protein expression in KRAS G12D gene delivery-based rat pancreatic cancer model to that of human pancreatic cancer. Last author DOI 10.1016/j.bbrc.2023.06.057↗
- Establishment of a pancreatic cancer animal model using the pancreas-targeted hydrodynamic gene delivery method. Last author DOI 10.1016/j.omtn.2022.03.019↗
- Rapid decline in visceral adipose tissue over 1 month is associated with poor prognosis in patients with unresectable pancreatic cancer. Last author DOI 10.1002/cam4.3964↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Osamu Shibata · 2 shared papers, 2022–2023 · strength 0.31
- Paper Similarity of oncogenic protein expression in KRAS G12D gene delivery-based rat pancreatic cancer model to that of huma… DOI 10.1016/j.bbrc.2023.06.057↗
- Paper Establishment of a pancreatic cancer animal model using the pancreas-targeted hydrodynamic gene delivery method. DOI 10.1016/j.omtn.2022.03.019↗
- Yuto Tanaka · 2 shared papers, 2022–2023 · strength 0.31
- Paper Similarity of oncogenic protein expression in KRAS G12D gene delivery-based rat pancreatic cancer model to that of huma… DOI 10.1016/j.bbrc.2023.06.057↗
- Paper Establishment of a pancreatic cancer animal model using the pancreas-targeted hydrodynamic gene delivery method. DOI 10.1016/j.omtn.2022.03.019↗
- Toshifumi Wakai · 1 shared paper, 2023 · strength 0.17
- Oki Nakano · 1 shared paper, 2021 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.